Synopsis: Spinal cord injury (SCI) is a debilitating condition that affects 12,000 people in the U.S. each year. There are three phases of SCI: acute (from the time of impact to the first few days post-injury), secondary (hours to weeks), and chronic (months to years). Current therapies focus on the secondary and chronic phases to promote healing and prevent further damage. However, little can be done to ameliorate the damage that occurs during the acute phase. I am currently studying the use of combinatory therapy to target both the acute and the chronic phase of spinal cord injury.
Biography: Luisa was born in Medellin, Colombia and moved to the United States at the age of 16. She attended SUNY Albany, where she majored in Biochemistry and Molecular Biology. As an undergraduate student, she participated in the AGEP Summer Research Institute, which greatly influenced her decision to enroll in the Molecular and Cellular Pharmacology doctoral program at Stony Brook University, where she is currently a fifth year student.